• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Alimentiv Acquires McDougall Scientific

    Q BioMed Inks Strontium89 Supply Pact

    PCI Pharma Services Appoints SVP, CFO

    AbbVie Opts to Acquire Mitokinin

    WuXi AppTec Completes OXGENE Acquisition
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Completes OXGENE Acquisition

    Celonic Group Announces Plans for New Facility in Switzerland

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Alimentiv Acquires McDougall Scientific

    WuXi AppTec Completes OXGENE Acquisition

    Live Webinar - Formulation Strategies for Poorly Soluble Molecules

    Celonic Group Announces Plans for New Facility in Switzerland

    Icon to Acquire PRA Health Sciences
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Syngene

    Cytovance Biologics

    Emergent BioSolutions

    Federal Equipment Company
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Emergent BioSolutions

    Reed-Lane

    Aphena Pharma Solutions

    Federal Equipment Company
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Capsule Technology Trends

    A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.

    Capsule Technology Trends
    Capsule Technology Trends
    Graph 1. In vitro dissolution of caffeine in Capsugel Vcaps Plus capsules.
    Related CONTENT
    • 20th Annual Contracting & Outsourcing Conference & Exhibition
    • Asymchem
    • Ackley Machine Corporation
    • Lonza Capsules and Health Ingredients
    • PCI Pharma Services
    Julien Lamps, Product Manager, Lonza10.14.20
    Orally administered medications are hands down, the world’s preferred way to take medications. According to Kiplinger, of the top 15 selling drugs in 2017, 8 out of 15 were oral solid dose (OSD) formulations, including the top seller.1 

    Despite the rise of parenterally administered biologics, many patients find injections stressful and inconvenient. For developers, OSD forms remain the preferred administration route due to their cost-effectiveness, relative ease of manufacturing and the wide availability of patient-friendly dosing options.

    For these reasons, there continues to be an increasing number of oral dose forms being approved and in development. In 2018, 53% of the new molecular entities (NMEs) approved by the FDA were OSDs. This portion of OSD approvals was higher than the previous two years (50% in 2017 and 32% in 2016).2

    In addition, although compressed tablet forms currently dominate OSD drugs overall, encapsulated therapeutics are a near second. This is largely driven by the fact that encapsulating active ingredients is seen as a reliable route for administering highly potent APIs as well as other compounds.

    In 2018, approximately 25% of new chemical entities (NCEs) were considered to be “potent,” a trend largely attributed to the fact that about one-third of all drug candidates being developed are oncology treatments.3,4 Of the 31 solid-dose oncological NMEs approved in 2018, seven were capsules.

    The rise of HPMC capsules
    Today, gelatin remains the most popular capsule material. Gelatin-based hard capsules offer traditional benefits and are supported by data to demonstrate compatibility. For a time, there were few alternatives that could offer the same characteristics. However, advances in materials science and organic chemistry are providing pharma’s drug developers with capsule materials that are derived from non-animal sources. These materials offer the same required performance, are compatible with APIs and drug products and cater to the growing patient demand for clean-label products.

    Hydroxy Propyl Methyl Cellulose (HPMC) capsules are becoming more popular in the marketplace. HPMC-based capsules show great promise as a potential alternative to gelatin-based formulations. Currently, HPMC-based capsules are widely preferred in clinical trials, and for many investigational NMEs, because they have the added flexibility to accommodate a vast array of drug products and formulations incompatible with gelatin capsules.4

    The need to deliver the potent APIs now under development is contributing to a shift towards encapsulating these formulations in HPMC-based capsules. However, there are other factors driving HPMC capsule demand, including:
    • Clean label, animal protein-free alternative to gelatin – addresses dietary and ethical concerns;
    • Processability and structural integrity; and
    • Source reliability and quality.
    Because of HPMC’s versatility and compatibility, pharmaceutical buyers are considering HPMC-based capsules for their new drug products.5

    The benefits of HPMC capsules
    When solid oral dosage forms were developed 10 to 20 years ago, the most common capsule material was gelatin, which remains popular today. This occasionally led to concerns around flexibility of hygroscopic formulations, as the plasticity of the shell was not maintained due to water exchanges between components.

    Modern HPMC capsules help to resolve this issue, offering a comparable dissolution profile to historical gelatin, while not mechanically suffering from the water exchanges.

    As a base material, HPMC offers higher moisture tolerance which helps to stabilize formulations and mitigates the challenges associated with APIs and excipients that are moisture sensitive.

    Due to the nature of HPMC, these capsules have lower moisture content than gelatin alternatives, which need more water to be plasticized and malleable. This low amount of water in shell will prevent hygroscopic API from accessing water and increase both their chemical and physical stability and subsequently their shelf life.

    The HPMC polymer can also withstand a wider range of temperature variation and fluctuation in storage and transit, meaning there is less chance for brittleness or breakage.

    Although gelatin capsules remain a strong candidate for new formulations, advancements in HPMC capsule technology are leading to broader compatibility with the more complex drug products being developed today. For example, there are emerging HPMC capsule technologies that eliminate gelling agents and provide for a standard, reliable alternative for delivering the next-generation of drug products.6 This results primarily from ion and pH independent dissolution behavior when using different dissolution media.

    Supporting medicine administration
    To develop an innovative oral delivery system without using a gelling agent, HPMC-based capsules have been optimized to stabilize formulation performance even in low humidity and moisture conditions, as well as when using various dissolution media.

    Composed of just HPMC and water with no gelling agent, Vcaps Plus HPMC capsules offer a consistent, pH-independent release of API and a more effective option relative to other HPMC capsules using gelling systems.

    Studies have shown that Vcaps Plus HPMC capsules deliver consistent disintegration and dissolution properties which helps optimize product performance. Moreover, gelatin-free HPMC capsules are suitable for moisture-sensitive ingredients, provide product stability and reduce risk of cross-linking.

    For example, Capsugel Vcaps Plus capsules, composed of HPMC without gelling agent, are exhibiting a fully pH-independent performance, as shown in Graph 1. This feature is addressing patient compliance concern, as it permits patients to take medication under fasted as well as under fed conditions.


    Graph 1. In vitro dissolution of caffeine in Capsugel Vcaps Plus capsules.

    Specific grades of HPMC are also the ideal tool for targeting release in the gastrointestinal tract (GI) tract. Targeting dispersion to occur along a specific point in the GI tract is proving to be an effective delivery strategy for certain therapeutics.6 Depending on the capsule’s film composition, this control can be relatively precise.

    The enteric version of capsules manufactured with Hydroxypropyl Methylcellulose Acetate Succinate (HPMC-AS) and HPMC can be utilized to greatly simplify and accelerate prototype development and rapid in-vivo testing of products requiring targeted delivery to the upper GI tract. For example, they eliminate coating system preparation and application steps; allow rapid screening and optimization of enteric performance; remove dependency of enteric functionality with process variability; and obviate the need for process development of the enteric coating step, process scale-up and validation. 

    References
    1. https://www.kiplinger.com/slideshow/investing/T027-S001-the-15-all-time-best-selling-prescription-drugs/index.html
    2. https://www.futuremarketinsights.com/reports/oral-solid-dosage-pharmaceutical-formulation-market
    3. https://www.pharmamanufacturing.com/articles/2019/solid-dose-under-hyped-but-not-under-represented/
    4. http://www.samedanltd.com/uploads/pdf/white_paper/9908ae04a14145d662675ac2eb0e0e5c.pdf
    5. https://www.ncbi.nlm.nih.gov/pubmed/21092714
    6. https://www.ncbi.nlm.nih.gov/pubmed/19900518


    Julien Lamps is Product Manager of Capsules and Health Ingredients at Lonza. He graduated from Ecole Nationale Supérieure de Chimie de Lille with an engineering degree in chemistry in 2004. Julien joined the company as a Quality Assurance Engineer in the Colmar plant in 2011. In this role he worked at the interphase of operations and customers within the well-known Capsugel Quality mindset. He specialized in coordinating new product introductions to develop innovative offers around modified release profiles and also inhalation products.
    Suggested For You
    20th Annual Contracting & Outsourcing Conference & Exhibition 20th Annual Contracting & Outsourcing Conference & Exhibition
    Asymchem Asymchem
    Ackley Machine Corporation Ackley Machine Corporation
    Lonza Capsules and Health Ingredients Lonza Capsules and Health Ingredients
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Bora Pharmaceuticals Bora Pharmaceuticals
    Iwata Label USA Iwata Label USA
    PharmaServe PharmaServe
    Regis Custom Pharma Regis Custom Pharma
    ViscoTec America ViscoTec America
    Sekisui Sekisui
    Antegene, WuXi Biologics Enter Oncology R&D Alliance Antegene, WuXi Biologics Enter Oncology R&D Alliance
    RedHill Biopharma Ramps-Up Manufacturing of Opaganib RedHill Biopharma Ramps-Up Manufacturing of Opaganib
    Pelican BioThermal Opens Strasbourg Service Center Pelican BioThermal Opens Strasbourg Service Center

    Related Features

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    • Selecting the Right Outsourcing Model for Emerging Biotech

      Selecting the Right Outsourcing Model for Emerging Biotech

      Flexible outsourcing models help drive quality, control costs and enable better efficiencies and faster delivery.
      Timothy King and Elisha Talley-Roithner, PPD 01.27.21


    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Biologics, Proteins, Vaccines
      The Future of Biologics: Accelerating Production, Reducing Costs

      The Future of Biologics: Accelerating Production, Reducing Costs

      Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.
      Mark Emalfarb, Dyadic 01.27.21

    • Analytical Services | Information Technology | Laboratory Testing
      Business Intelligence For (and From) the Lab

      Business Intelligence For (and From) the Lab

      How a digital ecosystem can harness the most data-rich environment in the CDMO.
      Bob Voelkner, VP Sales and Marketing, LabVantage 01.27.21


    • Communicating Your Contracting Priorities to Your Drug Company Customers

      Communicating Your Contracting Priorities to Your Drug Company Customers

      A discussion with Perrigo’s senior legal counsel, Susan Fyan, about issues that arise in very fact-specific contract negotiations between CDMOs and sponsors.
      Stephen Sayre, Dykema 01.27.21

    • COVID-19 Impact Report

      COVID-19 Impact Report

      Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21


    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    Trending
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • Spark Therapeutics Appoints CTO
    • The Future Of Vaccines And Biologics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • Alimentiv Acquires McDougall Scientific
    • Q BioMed Inks Strontium89 Supply Pact
    • PCI Pharma Services Appoints SVP, CFO
    • AbbVie Opts to Acquire Mitokinin
    • WuXi AppTec Completes OXGENE Acquisition
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Nouryon Agrees to Divest Salt Specialties Business to Salins Group
    PPG Appoints John Stephenson as Director, Acquisition Integration
    Hempel Reports 2020 Annual Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Varian CEO to Retire Following Siemens Healthineers Acquisition
    Olympus Purchases Israeli Firm Medi-Tate to Grow Urology Biz
    FDA Breakthrough Device Designation Awarded to BrainCool AB's Cooral System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Alimentiv Acquires McDougall Scientific
    Q BioMed Inks Strontium89 Supply Pact
    PCI Pharma Services Appoints SVP, CFO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Inter Parfums Reports a Strong Fourth Quarter
    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Happi

    Latest Breaking News From Happi

    Beiersdorf and Evonik Partner on Nature Conservation Project
    Jodie Foster Wears Biography Face Oil at the Golden Globes
    Lancôme Debuts Virtual Stores
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    CP Printing adds Colordyne 3800 Series AP – Retrofit
    Edale names SMAG Graphique distributor in France
    TLMI analyzes pandemic's effect on label industry in new report
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Domtar Completes Sale of Personal Care Business
    Mitsui to Sell Chinese Nonwovens Business
    Dr. J's Disinfectant Wipes Approved for Distribution in CA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Q-Collar Device Protect Athletes’ Brains During Head Impacts
    SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    Align Technology Inc. Executive Joins Zimmer Biomet Board
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login